Lamisil

Manufacturer
Physicians Total Care, Inc.
Effective date
2010-01-01
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 22:25:29

Label at a glance#

ProductLamisil
Active ingredientTERBINAFINE HYDROCHLORIDE
Label structure14 sections

Indications and uses

cures most jock itch (tinea cruris) relieves itching, burning, cracking, and scaling which accompany this condition

Dosage and administration

adults and children 12 years and over wash the affected area with soap and water and dry completely before applying to open remove clear cap. hold can 4" to 6" from skin.  Press and hold to spray a thin layer over affected area spray affected area once a day (morning or night) for 1 week or as directed by a doctor release to stop spray wipe excess from spray opening after each use return cap to can wash hands afte...

Storage and handling

store at 8° - 25° C (46° - 77° F)

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Terbinafine hydrochloride

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

  • cures most jock itch (tinea cruris)
  • relieves itching, burning, cracking, and scaling which accompany this condition

Warnings

WARNINGS SECTION

For external use only

Do Not Use

OTC - DO NOT USE SECTION

  • on nails or scalp
  • in or near the mouth or the eyes
  • for vaginal yeast infections

When using this product

OTC - WHEN USING SECTION

do not get into eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor

OTC - STOP USE SECTION

if too much irritation occurs or gets worse.

Keep Out of Reach of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control

Center right away.  

Directions

DOSAGE & ADMINISTRATION SECTION

  • adults and children 12 years and over
    • wash the affected area with soap and water and dry completely before applying
    • to open remove clear cap.
    • hold can 4" to 6" from skin.  Press and hold to spray a thin layer over affected area
    • spray affected area once a day (morning or night) for 1 week or as directed by a doctor
    • release to stop spray
    • wipe excess from spray opening after each use
    • return cap to can
    • wash hands after each use
  • children under 12 years: ask a doctor

Other information

STORAGE AND HANDLING SECTION

store at 8° - 25° C (46° - 77° F)

Additional Information

SPL UNCLASSIFIED SECTION

Full Prescription Strength

Continuous Spray Action

Cures Most Jock Itch

For Effective Relief of Itching & Burning

Distr. By:  

  • Novartis Consumer Health, Inc.
  • Parsippany, NJ 07054-0622 ©2009

Inactive ingredients

INACTIVE INGREDIENT SECTION

Ethanol, polyoxyl 20 cetostearyl ether, propylene glycol, purified water

Principal Display

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Relabeling of "Additional Barcode" by:
Physicians Total Care, Inc.
Tulsa, OK      74146

NDC 54868-6105-0
Lamasil At Continuous Spray
Lamasil At Continuous Spray

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
992536LamISIL AT 1 % Topical SprayPSN3
992535terbinafine HCl 1 % Topical SprayPSN3
992536terbinafine hydrochloride 10 MG/ML Topical Spray [Lamisil]SBD3
992535terbinafine hydrochloride 10 MG/ML Topical SpraySCD3
992536Lamisil 1 % Topical SpraySY3
992536Lamisil 10 MG/ML Topical SpraySY3
992536Lamisil AT 1 % Topical SpraySY3
992535terbinafine hydrochloride 1 % Topical SpraySY3

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
TERBINAFINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
55a24767-1759-5f6a-8888-ea4aa0adac21Product name120140508
db9701af-cb4f-b8ba-d282-6bc5b6b7c467Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
54868-6105-02019-09-24C16284748780-19350213a-426b-c013-e053-90daa90a1393Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
54868-6105-0Lamisil125 mL in 1 BOTTLE, SPRAYSPRAY1253

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
54868-6105LAMISIL (TERBINAFINE HYDROCHLORIDE) SPRAY [PHYSICIANS TOTAL CARE, INC.]31 package rows20100809_792eb340-7202-4c06-b488-033ca8a63859.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
54868-6105-0ML - Milliliter54868-610561d21a93-8c86-4fca-89ce-3d8942a030ce12012-07-24
0067-6293-83ML - Milliliter0067-62931eafdc82-7dfa-4915-9f4e-3c381bebeede12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
TERBINAFINE HYDROCHLORIDEACTIVE INGREDIENT012C11ZU6G3
TERBINAFINEACTIVE MOIETYG7RIW8S0XP3
ALCOHOLINACTIVE INGREDIENT3K9958V90M3
POLYOXYL 20 CETOSTEARYL ETHERINACTIVE INGREDIENTYRC528SWUY3
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V33
WATERINACTIVE INGREDIENT059QF0KO0R3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
54868-610554868-6105-0
0067-6293

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 147 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SYSTEM / TOPICAL4200 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION, SOLUTION / INTRAMUSCULAR4000 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSUSPENSION / RECTAL0.35 %v/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSHAMPOO / TOPICAL714 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / INTRAMUSCULAR400 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT, AUGMENTED / TOPICAL714 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPONGE / TOPICAL40 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
POLYOXYL 20 CETOSTEARYL ETHERPOLYOXYL 20 CETOSTEARYL ETHERYRC528SWUYGEL / TOPICAL2 %w/wExact identifier — unii candidate
7 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / RECTAL90400 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CONCENTRATE / ORAL7000 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, METERED / RESPIRATORY (INHALATION)26664 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / OPHTHALMIC0.6 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPRAY / NASAL5 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / RESPIRATORY (INHALATION)5 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, FOAM / TOPICAL4504 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / ORAL3563 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCONCENTRATE / ORAL198 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION / INTRAMUSCULAR1491 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / INTRAVENOUS99 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, METERED / RECTALNAExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / TOPICAL5148 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPRAY / SUBLINGUAL36 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL, METERED / TOPICAL1225 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MDROPS / ORAL210 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SYRUP / ORAL5700 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SHAMPOO, SUSPENSION / TOPICAL2 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / INTRAVENOUS16624 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL / TOPICAL9971 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CREAM, AUGMENTED / TOPICAL8 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, SPRAY / TOPICAL561 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY / TOPICAL3633 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCAPSULE / ORAL882 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSUSPENSION / ORAL681 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / OPHTHALMIC1 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / TRANSDERMAL49.37 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION, CONCENTRATE / INTRAVENOUS4000 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION / SUBCUTANEOUS149 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3JELLY / TOPICAL20 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, FILM COATED / ORAL96 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, EXTENDED RELEASE / ORAL8 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, FILM COATED, EXTENDED RELEASE / ORAL19 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUPPOSITORY / VAGINAL252 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY / TRANSDERMAL90 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, METERED / NASAL70 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION, EXTENDED RELEASE / ORAL1000 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL / RECTAL898 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / RECTAL3315 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, DELAYED RELEASE / ORAL36 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, FOAM / VAGINAL6.4 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TAMPON / VAGINAL62.1 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / TOPICAL4522 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY / SUBLINGUAL397 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL, METERED / TRANSDERMAL3675 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / INTRAVENOUS400 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CREAM / TOPICAL76000 mgExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION, EMULSION / INTRAVENOUS520 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL / TOPICAL19.2 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / RESPIRATORY (INHALATION)0.08 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / AURICULAR (OTIC)10 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / INTRAVENOUS50.33 %w/vExact identifier — unii candidate
81 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021124-001LAMISIL ATTERBINAFINE HYDROCHLORIDE1%SOLUTION / TOPICALRLD, RS2000-03-17
N021124-002LAMISIL ATTERBINAFINE HYDROCHLORIDE1%SPRAY / TOPICALRLD, RS2000-03-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-1784e616aacf4f…
2026-09-14 22:38:342026-08N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-1784e616aacf4f…
2026-08-18 06:07:402026-07N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-17caaa826d4ba7…
2026-08-18 06:07:402026-07N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-17caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-17011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-1731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-176a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-176a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-17fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-17fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-17b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-17b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-1703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-1703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-172680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-172680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-175bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-175bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-17d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-17d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-17d06236e962d9…
2024-10-29 15:01 UTC2024-10N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-17d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-1779d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-1779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-17301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-17301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-171e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-171e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-178072bd15b7f6…
2024-05-31 18:47 UTC2024-05N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-178072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-175c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-175c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-175d02ea3f76ae…
2022-04-08 23:34 UTC2022-04N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-175d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-174b0b4de00fa7…
2022-04-04 05:41 UTC2022-04N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-174b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021124-001LAMISIL AT1%SOLUTION / TOPICALRLD, RS2000-03-1774a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021124-002LAMISIL AT1%SPRAY / TOPICALRLD, RS2000-03-1774a2ff9319b5…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
db793c72-3826-4b5c-a32a-952cd3d85cd9792eb340-7202-4c06-b488-033ca8a638592010-01-01WarningsExact identifier
spl id: db793c72-3826-4b5c-a32a-952cd3d85cd9
spl set id: 792eb340-7202-4c06-b488-033ca8a63859

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.